P

Inventor

YOSHIDA TETSUHIKO

JP59 patents
⚠️ This page may combine multiple inventors who share the name “YOSHIDA TETSUHIKO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

TOAGOSEI CO LTD

41 patents
US11313862B2Apr 26, 2022

Method for diagnosing amyotrophic lateral sclerosis using signal peptide as indicator

TOAGOSEI CO LTD8 citations85
US7964556B1Jun 21, 2011

Antimicrobial peptides and use thereof

TOAGOSEI CO LTD9 citations83
US7482328B2Jan 27, 2009

Antimicrobial polypeptide and utilization thereof

TOAGOSEI CO LTD11 citations82
US12285476B2Apr 29, 2025

Amino acid sequence derived from S protein of SARS-CoV2 for generating an anti-SARS-CoV-2 antibody

TOAGOSEI CO LTD0 citations62
US11965011B2Apr 23, 2024

Antitumor peptide and use thereof

TOAGOSEI CO LTD0 citations62
US11927589B2Mar 12, 2024

Carrier peptide fragment for nucleolar localization and use thereof

TOAGOSEI CO LTD1 citations62
US11814448B2Nov 14, 2023

Carrier peptide fragment and use thereof

TOAGOSEI CO LTD0 citations62
US11780903B2Oct 10, 2023

Peptide suppressing binding of CTLA4 to B7 proteins, and use thereof

TOAGOSEI CO LTD0 citations62
US11603395B2Mar 14, 2023

Antitumor peptide and use thereof

TOAGOSEI CO LTD0 citations62
US11505589B2Nov 22, 2022

Antitumor peptide and use thereof

TOAGOSEI CO LTD0 citations62
US11352408B2Jun 7, 2022

Antitumor peptide having PD-1 signal sequence and utilization thereof

TOAGOSEI CO LTD0 citations62
US11339203B2May 24, 2022

Antitumor peptide and use thereof

TOAGOSEI CO LTD0 citations62
US11299555B2Apr 12, 2022

Method for diagnosing alzheimer's disease using signal peptide as indicator

TOAGOSEI CO LTD1 citations62
US10100284B2Oct 16, 2018

Method for inducing differentiation of pluripotent stem cells into endodermal cells

TOAGOSEI CO LTD2 citations62
US9353350B2May 31, 2016

Method for producing multipolar cell

TOAGOSEI CO LTD2 citations62
US9353351B2May 31, 2016

Method for producing multipolar cell

TOAGOSEI CO LTD2 citations62
US9296787B2Mar 29, 2016

Antitumor peptide and use thereof

TOAGOSEI CO LTD2 citations62
US11767345B2Sep 26, 2023

Antiviral peptide and use thereof

TOAGOSEI CO LTD0 citations60
US11155582B2Oct 26, 2021

Antiviral peptide and use thereof

TOAGOSEI CO LTD0 citations60
US7674771B2Mar 9, 2010

Antimicrobial peptides and utilization of the same

TOAGOSEI CO LTD4 citations60
US11230586B2Jan 25, 2022

Exosome production method

TOAGOSEI CO LTD1 citations59
US10981953B2Apr 20, 2021

Method for promoting expression of calreticulin, and synthetic peptide for use in method for promoting expression of calreticulin

TOAGOSEI CO LTD0 citations58
US11472845B2Oct 18, 2022

Antitumor peptide and use thereof

TOAGOSEI CO LTD0 citations57
US11285195B2Mar 29, 2022

Pharmaceutical composition for inhibiting expression of CD47 in tumor cells and use of same

TOAGOSEI CO LTD0 citations55
US11359180B2Jun 14, 2022

Method for producing myocardial cells using synthetic peptide

TOAGOSEI CO LTD0 citations52
US10421944B2Sep 24, 2019

Method for producing neural stem cells using synthetic peptide

TOAGOSEI CO LTD0 citations52
US10112977B2Oct 30, 2018

Peptide for inducing multinucleation in cells, and use therefor

TOAGOSEI CO LTD1 citations52
US7893031B2Feb 22, 2011

Neuronal differentiation inhibitor peptide and use thereof

TOAGOSEI CO LTD0 citations52
US7186510B2Mar 6, 2007

Method for evaluating uniformity of spots on an array

TOAGOSEI CO LTD1 citations52
US6907393B1Jun 14, 2005

Methods for screening candidates for artificial promotors

TOAGOSEI CO LTD0 citations52
US12392770B2Aug 19, 2025

Foreign substance introduction construct and use thereof

TOAGOSEI CO LTD0 citations51
US10125168B2Nov 13, 2018

Synthetic peptide for adjusting balance between presence of type 1 TNF receptor and type 2 TNF receptor and use thereof

TOAGOSEI CO LTD0 citations51
US9856293B2Jan 2, 2018

Methods for inducing nestin expression of astrocytes by nestin-inducing synthetic peptides derived from the BC-box of the SOCS6 protein

TOAGOSEI CO LTD0 citations51
US9480727B2Nov 1, 2016

Synthetic peptide for inhibiting expression of type 2 TNF receptor and use thereof

TOAGOSEI CO LTD1 citations51
US9370182B2Jun 21, 2016

Antimicrobial peptide and use thereof

TOAGOSEI CO LTD0 citations51
US7615534B2Nov 10, 2009

Antimicrobial peptides and use thereof

TOAGOSEI CO LTD0 citations51
US10745448B2Aug 18, 2020

Antiviral peptide and use therefor

TOAGOSEI CO LTD0 citations50
US11324831B2May 10, 2022

Method for introducing exogenous substance into cell, and material used in said method

TOAGOSEI CO LTD0 citations48
US12209242B2Jan 28, 2025

siRNA based on RNA sequence of SARS-CoV-2 and use thereof

TOAGOSEI CO LTD0 citations47
US9133437B2Sep 15, 2015

Cell proliferation-promoting peptide and use thereof

TOAGOSEI CO LTD0 citations46
US10046022B2Aug 14, 2018

Synthetic peptide that increases radiosensitivity of tumor cells and use of same

TOAGOSEI CO LTD1 citations45

TOA GOSEI KABUSHIKI KAISHA

2 patents

YOSHIDA TETSUHIKO

2 patents

KOBAYASHI NAHOKO

2 patents

FUKUSHIMA HITOSHI

1 patent

SHIMIZU NOBUYOSHI

1 patent

LIGHTRON CO LTD

1 patent

Showing the top 50 of 59 patents by PatentIndex Score.